FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY”, which is offered here for Printed instructional and educational materials used for counseling doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities;counseling to doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities;.
Its status is currently believed to be active. Its class is unavailable. “ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY” is believed to be currently owned by “Ranbaxy Laboratories Limited”.
| Owner: |
RANBAXY LABORATORIES LIMITED
Owner Details |
|---|---|
| Description: |
Printed instructional and educational materials used for counseling doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities;counseling to doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities;
|
| Categories: | PRINTED INSTRUCTIONAL EDUCATIONAL MATERIALS |